Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing

Frequent or Longer Naps in Older Age May Signal Declining Health, Study Suggests
A long‑term JAMA Network Open study of 1,338 older adults found that longer and more frequent daytime naps, especially in the morning, are linked to higher mortality. Each additional hour of napping raised death risk by 13%, and each extra nap added about 7% risk. Morning naps carried a 30% greater risk than afternoon naps, while stable nap habits showed no increase. Researchers suggest tracking nap patterns could serve as a simple early‑warning sign of health decline.

Keto May Work Best for Sending Diabetes Into Remission: Here's Why
A recent 12‑week study published in the Journal of the Endocrine Society compared a ketogenic (high‑fat, low‑carb) diet with a low‑fat diet in 51 adults aged 55‑62 with type 2 diabetes. Both groups lost weight, but the keto group exhibited a...
![[Video] AI in Healthcare: Five Healthcare AI Stories You Need to Know This Week - April 24, 2026](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://jdsupra-static.s3.amazonaws.com/profile-images/og.2237_4849.jpg)
[Video] AI in Healthcare: Five Healthcare AI Stories You Need to Know This Week - April 24, 2026
The weekly AI‑in‑Healthcare briefing highlighted five pivotal developments. UnitedHealth announced a $1.5 billion investment to embed AI across its payer and provider services. Merck unveiled a new AI‑driven commercial strategy aimed at deepening engagement with physicians, while Hartford HealthCare showcased a...

Can Corpus Replace Health Insurance
Health insurers in India paid roughly ₹32,000 crore ($3.9 bn) on 6.2 million claims in FY25, showing that the industry does settle the majority of claims despite a noisy trust deficit. The author argues that a personal savings corpus cannot replace a renewable...
From Patchwork to Platform: How Blue Cross Blue Shield Meets the Modernization Challenge
Blue Cross Blue Shield plans are confronting legacy technology debt and fragmented data silos, prompting a shift toward modular, cloud‑ready architectures. A HIMSS session outlined practical strategies—multicloud adoption, data unification, and robust governance—to boost agility and member experience. Speakers from...
A New Interoperability Strategy in the Age of Analytics and AI
A HIMSS webinar revealed that 86% of healthcare leaders view interoperability without data preparation as offering limited value for AI and analytics. The discussion urges providers to move beyond simple connectivity and embed data readiness into their interoperability strategies. InterSystems...
InterSystems Automates Bi-Directional Data Exchange Between Epic Payer Platform and Health Plan Workflows
InterSystems announced its Payer Connector, a bidirectional integration hub that links Epic Payer Platform with health‑plan IT systems. The solution transforms and routes data securely, reducing the need for point‑to‑point interfaces and speeding up deployment. It is now available through the Epic...

Clinical Trial Finds No Difference in Fluid Treatment Options for Pediatric Sepsis
A NIH‑backed trial involving more than 9,000 children across five countries compared balanced crystalloid fluid with standard 0.9% saline for pediatric septic shock. The study found no significant differences in mortality, persistent kidney dysfunction, or need for renal‑replacement therapy between...

RFK Jr. & White House Appear At Odds Over Attempts To Rein Him In
The Trump administration nominated Dr. Erica Schwartz, a former Deputy Surgeon General, to fill the long‑vacant CDC director post created after Susan Monarez’s dismissal in August 2025. Schwartz is widely praised for her evidence‑based public‑health background, but HHS Secretary RFK Jr....

Exposing Antivaccine Activism: Immunization Partnership’s Houston Talk
Many thanks Comedy Injection for hosting my remarks this evening in HoustonTX with @immunize_usa The Immunization Partnership promoting vaccine advocacy, detailing the dark forces of antivaccine activism in U.S. https://t.co/YbUvv0pOuS
Secure Medical Image Cryptanalysis with Quantum Neural Networks for IoT-Enabled Cloud Storage
The paper introduces a unified security framework for IoT‑enabled medical imaging that blends hybrid post‑quantum encryption, a quantum neural network for cryptanalysis, federated deep learning, and secure cloud storage. The hybrid scheme merges post‑quantum cryptography, chaos‑based diffusion, and AES‑GCM, while...
Shilpa Medicare Appoints Dr. Vellaian Karuppiah as COO to Drive Operational Growth
Shilpa Medicare Limited announced the appointment of Dr. Vellaian Karuppiah as chief operating officer. The veteran pharma executive will steer manufacturing, quality, regulatory compliance and supply‑chain functions as the company expands its global footprint.
Johnson & Johnson Beats Q1 2026 Earnings, Raises Full-Year Outlook
Johnson & Johnson reported first‑quarter 2026 revenue of $24.1 billion and adjusted earnings per share of $2.70, exceeding analyst expectations. The health‑care mega‑cap also lifted its full‑year sales forecast to $100.8 billion, driven by strong performance of Darzalex, Tremfya and early uptake...
Rob Thompson Named Chief Digital, Data & Technology Officer for DHSC and NHS England
The UK Department of Health and Social Care (DHSC) and NHS England have appointed Rob Thompson as their new Chief Digital, Data and Technology Officer. Thompson, who spent eight years leading digital transformation at the Home Office, will replace interim...
Four Major U.S. Insurers Commit to Uniform Electronic Prior Authorization Standards
Aetna, Cigna, Elevance and UnitedHealth announced a coordinated effort to create uniform electronic prior‑authorization standards across commercial, Medicare Advantage and Medicaid plans. UnitedHealthcare targets over 70% of its review volume by end‑2026, while Aetna already standardizes 88% of its volume,...
Rise Nano Optics Lands First U.S. Lab Partner to Launch SPECTRAGUARD™ Nanophotonic Lenses
Rise Nano Optics Ltd. has signed its first U.S. laboratory partnership with Sierra Optical Lab in Reno, Nevada, to bring its FDA‑registered Class I SPECTRAGUARD™ nanophotonic lens treatment to market. The deal gives the Canadian nanotech firm a foothold in...

DEA Reschedules FDA-Approved Marijuana Products and State-Licensed Medical Marijuana to Schedule III
On April 22, 2026, Acting Attorney General Todd Blanche signed a final order moving FDA‑approved marijuana products and state‑licensed medical cannabis from Schedule I to Schedule III. The change eliminates the Section 280E tax disallowance for medical operators and creates an expedited DEA...
No Country Ever Guarantees Claim Approval
There isn’t a single country in the world where claims for medical care are not sometimes denied. Not a single one.

Medspas on Alert: The FDA Says You’re a Dispenser Too
On April 1, 2026, the FDA issued its first warning letter to a “dispenser” of prescription drugs, targeting Texas‑based medspa Pure Indulgence Aesthetics for violations of the Drug Supply Chain Security Act. Inspectors cited use of unauthorized Botox suppliers, failure to provide...

Inhaled Treprostinil Improves FVC in IPF Phase 3 Trial: Steven D. Nathan, MD
A phase 3 double‑blind trial (TETON‑2) evaluated inhaled treprostinil in 539 idiopathic pulmonary fibrosis patients and demonstrated a statistically significant preservation of forced vital capacity versus placebo. At 52 weeks, the treprostinil arm showed a median FVC decline of –49.9 mL compared with...
Trump Administration Seeks Pause Of Lawsuit Challenging Vaccine Recommendations
On April 23, Trump administration lawyers filed a motion asking U.S. District Judge Brian Murphy to pause litigation that challenges recent CDC vaccine guidance updates made under Health Secretary Robert F. Kennedy Jr. The request argues that a stay pending...

One in Four Americans Use AI for Health Advice
25% of Americans have used an AI tool or chatbot for health information or advice, mainly as a supplemental tool for their care. https://t.co/6ca7WhHm49 https://t.co/f5Yv8ub4ff
Southwest Voices Clarifies Burnout vs Compassion Fatigue for Caregivers
Southwest Voices published a comprehensive guide that distinguishes burnout from compassion fatigue for healthcare workers, social workers and first responders. The piece highlights distinct causes, symptoms and coping pathways, aiming to improve self‑care and organizational support.
Emergency Cervical Cerclage Saves Taichung Mother After Cervix Shrinks Below 1 Cm
Doctors at Taichung Veterans General Hospital performed an emergency cervical cerclage on a 34‑year‑old mother when her cervical length fell below 1 cm at 24 weeks. The procedure extended the pregnancy to 37 weeks, resulting in the birth of a healthy full‑term daughter,...
Leukemia Survivor Runs London Marathon, Celebrates 30‑Year Survival and Fatherhood
Josh Catford, 30, will run the London Marathon this Sunday to raise money for Anthony Nolan, marking 30 years since he survived infant leukemia and celebrating his recent transition to fatherhood. The Dorset‑based category manager hopes the race will inspire more stem‑cell...
FDA Grants Quick Review Psychedelic Drugs, First Approvals Could Come As Soon As Summer
The FDA announced an accelerated review pathway for psychedelic therapies, aiming to clear the first approval by the end of summer. The move follows President Trump’s executive order, which allocates $50 million for state‑level research partnerships and directs faster rescheduling of...
Yifan Pharmaceutical Posts 4% Profit Rise on New Drug Launches
Yifan Pharmaceutical Co., Ltd. announced a full‑year profit of RMB402.02 million, up 4% from the prior year, as new product launches boosted earnings. Revenue slipped 0.5% to RMB5.132 billion, highlighting a shift toward higher‑margin offerings.
Samsung Biologics Q1 Profit Jumps 46% as Biopharma Demand Surges, but Labor Unrest Looms
Samsung Biologics posted a 45.9% jump in first‑quarter profit to KRW 640.6 billion (≈$493 million) on 25.8% revenue growth, underscoring booming biotech manufacturing demand. At the same time, its labor union warned of a May 1 strike if management does not address accountability concerns,...
HOPPR Launches Vision-Language Model to Convert Chest X‑Rays Into Structured Reports
HOPPR rolled out its MC CXR Narrative Model, a vision-language AI that turns chest X‑ray images into descriptive, structured text. The launch targets developers building radiology reporting tools and underscores the company’s push for adaptable, traceable AI infrastructure.
UnitedHealth Group Beats EPS Forecast, Shares Rise 2.2% on Strong Q1 Results
UnitedHealth Group reported first‑quarter earnings of $7.23 per share, beating the $6.76 consensus and delivering $111.65 billion in revenue, above expectations. The results lifted the stock 2.2% and underscored the health insurer’s defensive positioning amid a volatile market.
Roche Q1 Sales Slip 5% to $18.7B as Swiss Franc Gains Offset Drug Gains
Swiss pharma giant Roche posted first‑quarter sales of 14.7 bn Swiss francs ($18.7 bn), a 5% decline driven by adverse foreign‑exchange effects that wiped out underlying growth in its flagship drugs. The company confirmed full‑year targets, while its shares rose about 2%...

NO JAB, NO PAY/PLAY BILL COMING
New South Wales Libertarian MLC John Ruddick is drafting a bill to block the state’s “No Jab, No Pay/Play” policy, which ties family tax benefits and childcare subsidies to children’s vaccination status. The author of the post claims a recent...
UC Irvine Nanotech Exosome Therapy Reverses MS Symptoms in Mice
Scientists at the University of California, Irvine have demonstrated that bone‑marrow‑derived exosomes can deliver anti‑inflammatory cargo across the blood‑spinal cord barrier, fully reversing motor deficits and nerve damage in a mouse model of multiple sclerosis. The pre‑clinical results, published in...
Hippocratic AI Expands Footprint, Partners with Leading Health Systems to Improve Patient Outcomes
Hippocratic AI announced new collaborations with Cincinnati Children’s, UNC Health and the Gift of Life Marrow Registry, extending its safety‑first generative AI tools across pediatrics, primary‑care scheduling and donor outreach. The company’s AI Front Door and Nurse Co‑Pilot are now...
Tempest Therapeutics Hits Key Manufacturing Milestone for Dual-Targeting CAR‑T TPST‑2003
Tempest Therapeutics announced that its manufacturing partner, Cincinnati Children’s Applied Gene and Cell Therapy Center, received the TPST‑2003 lentiviral vector, a critical component for the dual‑targeting CD19/BCMA CAR‑T therapy. The milestone clears the path for a potential registrational trial later...
[Comment] Offline: President Trump—It Is Not Too Late
The Physicians for Human Rights report warns that recent U.S. cuts to global health funding under the Trump administration have crippled HIV/AIDS programs in South Africa, Kenya and other high‑burden countries. Primary‑care testing, PrEP distribution, antiretroviral therapy and research labs...
[Comment] Antibody-Based Malaria Prevention in an Intense Perennial Transmission Setting
A recent phase‑2 trial of the monoclonal antibody L9LS in Kenyan children demonstrated high efficacy against Plasmodium falciparum in an intense, year‑round transmission setting. The study reported roughly 70% protection after a single dose, with a safety profile comparable to...

Data Security Is a Question of Trust
UK Biobank discovered that de‑identified health data from its 500,000‑volunteer cohort appeared on a Chinese Alibaba auction site, prompting a rapid joint response from the biobank, Alibaba and UK and Chinese authorities. The leak was traced to three accredited researchers...
If We Can Fund a $200 Billion War, Why Not Fund Food Security at Home?
The Pentagon is seeking over $200 billion to expand a war with Iran, a sum that could instead fund a generational push for food security in the United States. Poor diet contributes to the disqualification of most young Americans from military...

‘Searching For Drug Peace’ Trailer: Hot Docs Film Explores “Daring Reform Activist” Waging War On The War On Drugs
The documentary *Searching for Drug Peace* will debut at Hot Docs in Toronto on April 28, 2026, chronicling activist Dana Larsen’s battle against the North American War on Drugs. The film highlights the staggering overdose toll—nearly 80,000 deaths in the U.S. in...

While SF Sees Fewer Fatal Overdoses, Death Rate Is Still Among the Country’s Worst
San Francisco reported 49 accidental drug overdose deaths in March, bringing the year‑to‑date total to 148. While the monthly and YTD figures represent a decline from previous years, the city’s overdose death rate still ranks among the nation’s highest. Officials...
Utah Medical Board’s Call To Halt AI Drug Pilot Triggers Med Practice Showdown
Utah’s medical board has ordered an immediate pause on the state’s pioneering AI‑driven prescription renewal pilot, the first of its kind in the nation. The pilot, launched by a consortium of health systems and a tech vendor, used machine‑learning algorithms...
![His Mother-in-Law Heard “Cancer,” Went Home, and Was Dead Within a Year [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/Design-1-1-scaled.jpg)
His Mother-in-Law Heard “Cancer,” Went Home, and Was Dead Within a Year [PODCAST]
Alan P. Feren, a retired surgeon and patient advocate, discusses the concept of “unfinishedness” in medicine—where clinicians achieve administrative closure but leave patients without clear clinical reasoning. He illustrates the issue with his mother‑in‑law’s early chronic lymphocytic leukemia diagnosis, where she...
Undetected Antibodies Can Undermine Phage Therapy Effectiveness
Hidden antibodies in patients can neutralize bacteriophages, limiting the effectiveness of phage therapy for drug-resistant infections and highlighting the need for pre-treatment antibody screening. infectiousdisease
AI‑empowered Patients Demand Smarter Clinician Collaboration
Patients are empowered by AI in a way they've never been before. This raises the bar for clinicians everywhere. I'm hearing from clinicians that their patients now come to clinic having done tremendous amounts of research on themselves and their conditions...

CMS Proposes Electronic Prior Authorization for Drugs
The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule to extend electronic prior authorization (e‑PA) to pharmaceuticals covered under both medical and pharmacy benefits. The rule mandates the use of Fast Healthcare Interoperability Resources (FHIR) APIs...

Federal Action Needed to Mirror Colorado’s Cannabis Reform
It’s time for the federal government to catch up to states like Colorado on safe, regulated cannabis. Expanding research and reducing barriers moves policy in a more rational direction and improves public safety. There’s more to do, but this is...
Targeting iNOS‑IRG1 Binding Offers Precise Anti‑Inflammatory Therapy
A newly discovered interaction between iNOS and IRG1 proteins directly regulates inflammation, suggesting that targeting their physical binding could offer more precise therapies for Crohn's disease, arthritis, and cardiovascular conditions. immunology

‘We’re Not Prepared to Replace Them’: Immigration Changes Hit Nursing Homes Hard, Undermining Workforce Stability
Recent U.S. immigration policy shifts—most notably a $100,000 fee for new H‑1B petitions and tighter temporary protected status rules—are threatening the nursing‑home labor pipeline. Immigrants already represent roughly 40% of staff at Georgia‑based A.G. Rhodes and 21‑25% nationwide, especially in...
Bipartisan Bill Expands Childhood Vaccine Access via VFC
Thank you @RepKimSchrier and @RepJohnJoyce for introducing bipartisan legislation to expand childhood vaccine access through the Vaccines for Children Program ⤵️